Results 191 to 200 of about 36,341 (274)

Intrathecal baclofen therapy in patients with spastic paraplegia: retrospective evaluation of pretreatment drugs, test dosage, dose increments and final therapy. [PDF]

Brain Spine
Kurz S, Marth LM, Hoffmann CH, Maria Kummerant JH, Schneckmann FW.   +4 more
europepmc   +1 more source

Effect of baclofen on physiotherapy in the management of spastic cerebral palsy

, 2020
Tabassum Ali, C. Mohanty, Rajniti Prasad, Biplab Das   +3 more
openalex   +2 more sources

Synthesis of chiral lactams by asymmetric nitrogen insertion. [PDF]

Chem Sci
Hammes J, Mañas C, Pedada A, Arnold M, Wahl JM.   +4 more
europepmc   +1 more source

Challenges of patients with intrathecal baclofen pump therapy during COVID-19 pandemic in Saudi Arabia

Ahmad Zaheer Qureshi, Hasan Shacfe, Mohammed Jameel, Waqas Sami, Imad Saeed Moukais, Fares Qannam, Lady Lynn Salazar Ortega, Tariq Ahmad Wani   +7 more
openalex   +1 more source

Life-threatening baclofen toxicity in ESRD: a case report. [PDF]

CEN Case Rep
Taira S, Tamayose S, Kikumura T, Nishihira M.   +3 more
europepmc   +1 more source

Stereochemical Controlof Cocrystal and Hybrid Salt–CocrystalFormation in the Baclofen–Mandelic Acid System

Sarita Songsermsawad (12239756), Kajjana Boonpalit (11948660), Oleksii Shemchuk (3355310), Koen Robeyns (1415809), Tom Leyssens (1556803), Adrian E. Flood (2184750)   +5 more
openalex   +1 more source

Genetic and clinical characterization of SPG10: a case series of novel pathogenic variants and phenotypic diversity. [PDF]

Ann Med Surg (Lond)
Mansour AN, Karadima G, Koutsis G, Salloum S.   +3 more
europepmc   +1 more source

EFFECTS OF BACLOFEN AND PHENMETRAZINE ON NEURONAL SIGNALING PATHWAYS IMPLICATED IN PSYCHOSTIMULANT ADDICTION

, 2016
Bradley M. Keegan
openalex   +1 more source

GABA_B Receptors Mediate Intracellular Calcium Release in Astrocytes of the Prefrontal Cortex. [PDF]

Eur J Neurosci
Bostel J, Kürten AJ, Beiersdorfer A.
europepmc   +1 more source

Modeling presynaptic inhibition by the amyloid precursor protein demonstrates one potential mechanism for preventing runaway synaptic modification in Alzheimer's disease. [PDF]

Alzheimers Dement
Barber D, Hasselmo ME, Rice HC.
europepmc   +1 more source